The study aimed to comprehensively evaluate the potential effects of XZF through multiple mechanisms: its effects on CD4+ and CD8+ T-cell function, its impact on macrophage-mediated antitumor responses, and its ability to modulate the PD-L1/PD-1 pathway in both prostate cancer and T-cells. The gene discussed is PDCD1; the disease is Familial prostate cancer.